Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV­1 infection

Paula, Hury Hellen Souza de; Ferreira, Ana Cristina Garcia; Caetano, Diogo Gama; Delatorre, Edson; Teixeira, Sylvia Lopes Maia; Coelho, Lara Esteves; João, Eduarda Grinsztejn; Andrade, Michelle Morata de; Cardoso, Sandra Wagner; Grinsztejn, Beatriz; Veloso, Valdiléa G.; Morgado, Mariza Gonçalves; Guimarães, Monick Lindenmeyer; Côrtes, Fernanda Heloise.
Artículo en Inglés | ARCA | ID: arc-30894

Documentos relacionados

  1. Executive summary. Consensus document of GESIDA and SPNS (Spanish Secretariat for the National Plan on AIDS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)
  2. Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection.
  3. Rapid antigen detection test for respiratory syncytial virus diagnosis as a diagnostic tool
  4. Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities.
  5. The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia.
  6. Long-term Therapeutic Impact of the Timing of Antiretroviral Therapy in Patients Diagnosed With Primary Human Immunodeficiency Virus Type 1 Infection.
  7. The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients.
  8. Tryptophan catabolism and immune activation in primary and chronic HIV infection.